MONDAY, March 4 (HealthDay News) -- Asthma patients typically use two inhaled drugs -- one a fast-acting "rescue inhaler" to stem attacks and another long-lasting one to prevent them.
However, combining both in one inhaler may be best for some patients, two new studies suggest.
Patients with moderate to severe asthma who used a combination inhaler had fewer attacks than those on two separate inhalers, researchers report. Both studies tested the so-called SMART (single maintenance and reliever therapy) protocol.
"The SMART regime was more effective as a treatment for asthma than the conventional treatment, where you just use a inhaler at a fixed maintenance dose and a short-acting inhaler for the relief of symptoms," said Dr. Richard Beasley, director of the Medical Research Institute of New Zealand in Wellington and lead researcher of one of the studies.
These drugs are a combination of a corticosteroid (such as budesonide or fluticasone) and a long-acting beta-2 agonist (such as salmeterol or formoterol) and are sold under various brand names including Seretide, Symbicort and Advair.
In asthma, treatment increases as the severity of the condition does, Beasley said. So, this combination therapy isn't the first choice. When the asthma is difficult to control with other methods, "we are now recommending the SMART regime," he said.
"You treat the patients according to their needs," Beasley said. "This is certainly not what you start them on -- it is something you would use on moderate to severe patients."
In the United States, use of these combination inhalers is also not considered first-line therapy for asthma, according to Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City.
"Patients, however, are currently using these combination inhalers," he said. If the asthma is moderate to severe, then a combination inh
All rights reserved